Wang, Y., Chen, X., Huang, R. (2026). Postoperative adjuvant donafenib-based therapy for patients with hepatocellular carcinoma at high risk of recurrence.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16256